CONTINUING EDUCATION:
RN, NP:  .92 CE Credit (0.5 Pharmacology)

Recorded Date:  April 10, 2015 (as part of the 2015 PCNA annual symposium in Anaheim)
Original Posting Date: January 27, 2016
Content Review Date: January 2017

COURSE OVERVIEW:

Dr. Donald Lloyd-Jones, thought leader who played a major role in the development of the 2013 risk assessment and prevention guidelines takes the learner through a case-based approach in the clinical application of the guidelines. 

EDUCATIONAL OBJECTIVES:

  • Describe process for assessing appropriateness for statin therapy in the high risk primary prevention patient
  • Describe steps in the addition of non-statin therapy to the treatment regimen of a patient with residual risk.

AUDIENCE:
Nurses, advanced practice nurses, and other healthcare providers interested in the prevention and management of cardiovascular disease.

FACULTY DISCLOSURES:
The faculty members have declared no commercial relationships related to the content of this presentation.

COST:
This online educational activity is offered free of charge.

PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the course materials; complete the post-test (you can take the post-test more than once if needed to achieve a passing score of 75%) and online evaluation form at the end of the activity, and print your CE certificate.

ACCREDITOR:
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Association of Nurse Practitioners (AANP) as an approved provider of Nurse Practitioner continuing education, provider number 030602. 

Please note that if you received credit for attending the 2015 PCNA Annual Symposium in Anaheim, you will be unable to claim credit for the on-demand sessions that were recorded there.  

Seminar Information
Seminar Date:
April 10, 2015
Seminar Objectives
  • Describe process for assessing appropriateness for statin therapy in the high risk primary prevention patient
  • Describe steps in the addition of non-statin therapy to the treatment regimen of a patient with residual risk.
What's a Clinician to Do? Implementation of the 2013 Prevention Guidelines
Speaker Information
Donald Lloyd-Jones
Individual topic purchase: Selected

PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the course materials; complete the post-test (you can take the post-test more than once if needed to achieve a passing score of 75%) and online evaluation form at the end of the activity, and print your CE certificate.


ACCREDITOR:

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. 

 

Preventive Cardiovascular Nurses Association
Pharmacology Hours: 0.50
General Hour: 0.42
Products
What's a Clinician to Do? Implementation of the 2013 Prevention Guidelines
PCNA Member Price:$0.00
Non-Member Price:$0.00